Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.
about
The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.Medical management of metabolic dysfunction in PCOS.Targets to treat metabolic syndrome in polycystic ovary syndromeComparing the Effect of Metformin and Acarbose Accompanying Clomiphene on the Successful Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome.GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.
P2860
Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Metformin versus acarbose ther ...... randomised double-blind study.
@ast
Metformin versus acarbose ther ...... randomised double-blind study.
@en
type
label
Metformin versus acarbose ther ...... randomised double-blind study.
@ast
Metformin versus acarbose ther ...... randomised double-blind study.
@en
prefLabel
Metformin versus acarbose ther ...... randomised double-blind study.
@ast
Metformin versus acarbose ther ...... randomised double-blind study.
@en
P2093
P2860
P1476
Metformin versus acarbose ther ...... randomised double-blind study
@en
P2093
Aida Hanjalic-Beck
Boris Gabriel
Christoph Keck
Dominik Denschlag
Hans-Peter Zahradnik
Marcus Schories
Wolfgang Schaefer
P2860
P304
P356
10.3109/09513591003686379
P577
2010-09-01T00:00:00Z